Black Diamond Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Black Diamond Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2020 to Q3 2024.
  • Black Diamond Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $19.8M, a 12.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $19.8M -$2.93M -12.9% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $20.5M -$2.89M -12.4% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $21.3M -$2.85M -11.8% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $22M -$2.81M -11.4% Dec 31, 2023 10-Q 2024-11-05
Q3 2023 $22.7M -$2.84M -11.1% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $23.4M -$2.82M -10.7% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $24.1M -$3.03M -11.2% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $24.8M -$2.91M -10.5% Dec 31, 2022 10-K 2024-03-12
Q3 2022 $25.5M -$2.83M -9.96% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $26.2M +$13M +99% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $27.1M +$13.3M +96.7% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $27.7M +$19.3M +230% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $28.4M +$19.9M +235% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $13.2M +$12.8M +3351% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $13.8M +$13.4M +3116% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $8.4M Dec 31, 2020 10-K 2022-03-17
Q3 2020 $8.46M Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $382K Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $429K Mar 31, 2020 10-Q 2020-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.